To directly examine the effect of DPI on human KCs from NFALD patients, we purified KCs from two additional NAFLD patients and performed the transcriptional analysis by RNA-seq following DPI treatment ex vivo for 24 h. This evidence concerns the gene TBCE and metabolic dysfunction-associated steatotic liver disease.